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Background: Our previous study of 29 obese food addiction (FA) patients found that FA
is associated with lipid profiles and hormones which may be a factor in cardiovascular
disease (CVD) and insulin resistance (IR). However, there is currently no data available
regarding the relationship between FA symptoms and metabolic characteristics of CVD
and IR in the general population. We designed this study to investigate the correlation
between FA symptoms with lipid profiles and IR in men and women of the general
Newfoundland population.
Methods: 710 individuals (435 women and 275 men) recruited from the general
Newfoundland population were used in analysis. FA symptoms were evaluated using
the Yale Food Addiction Scale (YFAS). Glucose, insulin, HDL, LDL, total cholesterol and
triglycerides levels were measured. IR was evaluated using the homeostatic model of
assessment (HOMA). Participants were grouped by sex and menopausal status. Age,
physical activity, calories and total % body fat were controlled.
Results: Partial correlation analysis revealed that in men, YFAS symptom counts were
significantly correlated with HOMA-β (r = 0.196, p = 0.021), triglycerides (r = 0.140,
p = 0.025) and inversely correlated with HDL (r = −0.133, p = 0.033). After
separating by menopausal status, pre-menopausal women exhibited no correlations
and post-menopausal women had a significantcorrelation with triglycerides (r = 0.198,
p = 0.016).
Conclusion: FA is significantly correlated with several markers of metabolic disturbance
in men and to a lesser extent, post-menopausal women, in the general population.
Further research is required to explain sex specific associations and elucidate any
potentially causal mechanisms behind this correlation.
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INTRODUCTION
Obesity rates have been climbing for the last three decades and
according to a report from Statistics Canada, in Newfoundland
(NL), 31% of adult women and 27.3% of men are obese (1, 2).
It follows that the population of NL also exhibit some of the
highest rates of obesity related health issues in Canada such as
type II diabetes (TIID) and cardiovascular disease (CVD) which
makes obesity research within this population so vital. Recent
reports put the rate of TIID in this Province at 11.2% with CVD
contributing to 20–38% of total deaths in adults aged 35 years or
older (3–5). The development of obesity is highly complex and is
comprised of a number of interacting genetic, environmental and
behavioral factors (6–9). One issue that highlights this intricate
balance of factors is that of an addictive tendency toward food.
This is characterized by an obsessive consumption of foods
known to be highly palatable with corresponding activation of the
bodies reward systems and significant difficulty controlling this
behavior (10). Previous research on food addiction discovered
there are tangible neural correlates in the way of dopaminergic
circuitry activity and it has drawn comparisons to nicotine
addiction in regards to how the body’s reward systems are effected
(11, 12).
Symptoms of an addictive tendency toward food are
quantified using the Yale Food Addiction Scale (YFAS) which
has been adapted from the criteria for substance abuse from
the DSM-IV TR (13). Foods that display addictive qualities are
those that are high in simple sugars, saturated fat and are heavily
processed. One study revealed that the processing of food was a
strong predictor of it possessing addictive qualities (14). There is
substantial evidence that these very same types of foods can have
a significant negative impact on health. Foods high in fructose
can be highly lipogenic and could lead to an increased risk of
developing non-alcoholic fatty liver disease and consequently,
TIID (15). A study concerning consumption of sugar sweetened
beverages effects on health looked at over 310,000 individuals and
over 15,000 TIID patients and found that those in the highest
quartile of sugar sweetened beverage consumption had a 26%
higher risk of developing TIID (16). Excessive sucrose intake has
also been found to be associated with a 37% increased risk of
having a coronary event (17). Furthermore, a 13 years follow up
study performed on 4,999 individuals found that consumption of
milk fats, various sweets and cake was associated with increased
CVD risk in women (18). In addition to the behavioral and
neurological evidence supporting the role of addictive food
tendencies in health, we have recently found that there are
different hormonal characteristics between food addicted (FA)
and non-food addicted (NFA) individuals.
We have previously discovered that obese food addicts had
lower levels of thyroid stimulating hormone (TSH), tumor
necrotic factor alpha (TNF-α) and amylin but higher levels of
prolactin compared to non-food addicted obese individuals (19).
TSH levels have previously been implicated in the development
of insulin resistance (IR) and diabetes while TNF-α has been
shown to decrease appetite, therefore, lower levels of TNF-
α may exasperate obesity related comorbidities by lending to
increased positive energy imbalance (20–22). Amylin is known to
be associated with development of type 1 and TIID and increased
prolactin levels have been shown to be a cardiovascular risk
factor with correlations to diabetes as well (23–26). However,
our previous study was performed with only 58 individuals (29
FA obese, 29 NFA obese). Many studies in the field of “food
addiction” focus on specific sub-populations such as the obese,
bariatric surgery patients or those with an eating disorder (27,
28). What remains to be seen is whether or not an addictive
tendency toward food displays an association with metabolic
markers and hormones in the general population, specifically IR
and lipid profiles as these metabolic characteristics play a role in
the development of TIID and CVD (29, 30).
The very same types of foods that possess addictive qualities
are demonstrably dangerous to an individual’s overall health
when frequently consumed. It is therefore essential that the
association between addictive tendencies toward food and
metabolic markers of TIID and CVD be studied in the general
population. Our investigation was performed in a sub-group of
the CODING (Complex Diseases in a Newfoundland Population:
Environment and Genetics) study which consists of biochemical
and body composition data from over 3,200 men and women
from the general Newfoundland population.
MATERIALS AND METHODS
Participants
Seven hundred and ten adults (435 women, 275 men) from the
Province of Newfoundland and Labrador were recruited for this
study through the use of advertisements, flyers and word of
mouth. Eligibility requirements are as follows: (1) 19 years of
age or older. (2) The participant must have been born in NL
and the participant’s family must have been in NL for at least 3
generations. (3) Healthy with no serious metabolic, endocrine or
cardiovascular conditions. (4) Participant must not be pregnant
at time of study.
We have also excluded participants who have been found to
have “food addiction” in our previous study, from correlational
analysis but later included food addicted individuals for an
additional comparative analysis. Individuals who self-reported
having diabetes or hypertension were also excluded from this
analysis.
Food Addiction Symptom Count
Measurement
Symptoms of food addiction were assessed using the YFAS. This
is a 25-item questionnaire which assesses the last 12 months
of eating patterns. The YFAS is based on the criteria used for
substance dependence in the Diagnostic and Statistical Manual
IV TR (DSM-IV TR). This criterion includes symptoms such as
tolerance, withdrawals, anxiety in social situations, and difficulty
lowering or quitting use of substance. Symptoms were counted
using the Likert scoring method which ranges from 0 to 7
(13). Each symptom on the YFAS represents a collection of
questions concerning that particular behavior. If a participant
answers affirmatively to certain questions, they are said to
have the corresponding symptom. Some of these questions are
based on the frequency of the behavior (ex. once a month,
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2–4 times a month, etc.) and some are binary yes or no
questions (10). In our comparison of food addicts and non-food
addicts, those classified as food addicts were required to have
at least 3 symptoms and answer affirmatively to one of the two
questions from the YFAS which indicate clinically significant
dependence.
Caloric Intake and Physical Activity
Assessment
Calorie intake was measured using the Willett Food Frequency
Questionnaire (FFQ) which measures the last 12 months of
dietary habits (31). The quantity of each food item was
converted into a daily average intake value. This value was
then entered in the Nutribase Clinical Nutrition Manager
(software version 9.0; Cybersoft inc. Arizona). We employed
the use of the Baecke physical activity questionnaire to assess
physical activity levels. This questionnaire measures physical
activity using three categories which are work, sport and
leisure.
Body Composition and Metabolic Marker
Measurements
Body composition measurements, which in this study
included total body fat, was assessed using dual-energy x-
ray absorptiometry (DXA; Lunar Prodigy; GE Medical Systems,
Madison, WI, USA). Measurements were taken while patient
lied horizontally on DXA scanner following a 12 hour fast.
Serum concentrations of glucose, total cholesterol, HDL
cholesterol and triacylglycerols were measured using the
Lx20 analyzer (Beckman Coulter Inc., Fullerton, CA) with
Synchron reagents. LDL cholesterol was calculated using the
following formula: (total cholesterol)—(HDL cholesterol)—
(triacylglycerols/2.2). Serum insulin was measured using the
Immulite Immunoassay analyzer. Insulin resistance and beta cell
function were calculated using the homeostasis model assessment
(HOMA) (32).
Statistical Analysis
All statistical analysis was completed using SPSS ver.23. The level
of statistical significance was set at P < 0.05. Statistical tests were
run on men and women separately. Pearson correlation analysis
was used to evaluate potential relationships between YFAS
symptom counts and all metabolic markers. Partial correlation
analysis was also performed which allowed us to control for
age, total calorie intake, physical activity levels, and total body
fat % as necessary. An independent t-test was run between
BMI matched food addicts and a control group to assess the
difference of mean in the metabolic markers that were measured.
Control variables were selected for each gender dependent on
whether the potentially confounding variable in question shared
a significant association with both dependent and independent
variables. Following this method, we chose to control for age,
physical activity, total body fat % and calories. In order to better
normalize distribution of the data, HOMA-IR, and HOMA-β
were square root transformed.
RESULTS
Physical Characteristics and Adiposity
Measures
The age, gender, BMI and anthropometric data of all men
and women who participated in this study are presented in
Table 1A as mean ± standard deviation. The average age of
female participants was 45.4 years and the average age of male
participants was 42.9 years. There was a significant difference
observed between men and women for height, weight, BMI,
total % body fat, waist and hip measurements with men being
higher for each measure. There was also a significant difference
observed between pre and post-menopausal women for age,
height, waist and hip circumference as well total body fat %which
is highlighted in Table 1B.
Metabolic Characteristics
Men had much higher levels of glucose and triglycerides
compared to women. Women, however, had significantly higher
levels of HDL cholesterol (Table 2A). All othermarkers including
insulin, HOMA-IR, HOMA-β, LDL and total cholesterol were
not significantly different between men and women. Metabolic
characteristics were also compared between pre and post-
menopausal women (Table 2B). Post-menopausal women had
notably higher levels of insulin, glucose, and triglycerides in
addition to higher levels of both LDL and total cholesterol.
Correlations Between YFAS Symptoms and
Metabolic Markers
The Pearson and partial correlation coefficients as well as p-
values are presented in Tables 3–6. Men exhibited significant
Table 1A | Physical characteristics of participants.
Female Male
Mean ± SD Mean ± SD
n = 435 n = 275
Age* 45.4 ± 13.4 42.9 ± 12.9
Min-max 18.1–90.0 18.9–78.5
Height (cm)* 163.3 ± 6.1 177.6 ± 6.6
Min-max 144.0–187.6 156.8–200.0
Weight (kg)* 70.1 ± 14.6 90.5 ± 17.2
Min-max 44.2–132.2 57.1–149.5
BMI* 26.3 ± 5.5 28.3 ± 4.6
Min-max 16.9–53.6 19.0–43.3
BF%* 36.6 ± 8.6 26.2 ± 8.3
Min-max 12.5–58.6 5.3–45.5
Waist (cm)* 90.4 ± 13.5 100.9 ± 13.4
Min-max 62.0–139.5 64.9–140.0
Hip (cm)* 99.1 ± 12.6 101.4 ± 10.6
Min-max 75.0–148.0 78.0–135.0
Waist/Hip (cm)* 0.91 ± 0.07 1.0 ± 0.05
Min-max 0.68–1.62 0.75–1.14
*significant difference between men and women (p < 0.05) Mean ± Standard Deviation
(SD), (Minimum-Maximum), BF%- Total Body Fat Percent.
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Table 1B | Physical characteristics of pre and post-menopausal women.
Pre Post
Mean ± SD Mean ± SD
n = 277 n = 158
Age* 37.7 ± 9.3 58.2 ± 8.3
Min-max 19-56 37-90
Height (cm)* 164.2 ± 6.16 161.8 ± 5.66
Min-max 144–188 150.0–179.0
Weight (kg) 69.2 ± 14.3 71.6 ± 15.0
Min-max 39.0–119.0 48.0–132.0
BMI 25.7 ± 5.32 27.2 ± 5.53
Min-max 17.0–44.4 18.2–54.0
BF%* 34.9 ± 8.91 39.4 ± 7.40
Min-max 13.0–56.0 20.0–58.6
Waist (cm)* 88.0 ± 13.4 94.2 ± 12.8
Min-max 63.0–139.5 62.0–139.0
Hip (cm)* 96.9 ± 12.4 102.6 ± 12.0
Min-max 74.0–140.0 75.0–148.0
Waist/Hip (cm) 0.91 ± 0.08 0.92 ± 0.06
Min-max 0.75–1.62 0.68–1.06
*significant difference between men and women (p < 0.05)Mean ± Standard Deviation
(SD), (Minimum-Maximum), BF%- Total Body Fat Percent.
Table 2A | Metabolic characteristics of men and women.
Female Male
Mean ± SD Mean ± SD
n = 435 n = 275
Insulin 77.8 ± 94.1 79.3 ± 53.7
HOMA-IR 2.90 ± 5.50 3.20 ± 3.30
HOMA-β 136.9 ± 123.8 122.8 ± 78.1
Glucose* 5.06 ± 0.60 5.55 ± 1.52
Triglycerides* 1.09 ± 0.69 1.35 ± 1.00
HDL* 1.51 ± 0.37 1.23 ± 0.29
LDL 2.98 ± 0.89 3.13 ± 1.00
Cholesterol 5.05 ± 0.96 5.06 ± 1.08
*significant difference between men and women (p < 0.05)Mean ± Standard Deviation
(SD), HOMA-IR, Homeostatic Model of Assessment-Insulin Resistance; HOMA-β,
Homeostatic Model of Assessment-Beta Cell; HDL, High Density Lipoprotein; LDL, Low
Density Lipoprotein.
positive correlations between YFAS symptoms and HOMA-
β, TG as well as a significant negative correlation with HDL
cholesterol (Table 3). In men the correlation between YFAS
symptoms and HOMA-IR just barely missed the cut-off of for
statistical significance at α = 0.05 (r = 0.164, p = 0.053).
These correlations remained significant after controlling for
age, physical activity, total body fat % and calories. YFAS
symptoms counts in women exhibited nosignificant correlations
(Table 4) however, when separated by menopausal status, post-
menopausal (Table 5) women showed a significant correlation
with TG (r = 0.198) after controlling for age, physical activity,
total body fat % and calories. Pre-menopausal women exhibited
Table 2B | Metabolic characteristics of pre and post menopausal women.
Pre Post
Mean ± SD Mean ± SD
n = 277 n = 158
Insulin* 66.0 ± 50.6 92.4 ± 127.9
HOMA-IR 2.23 ± 1.62 3.68 ± 7.86
HOMA-β 139.4 ± 139.1 134.8 ± 104.2
Glucose* 4.93 ± 0.46 5.28 ± 0.74
Triglycerides* 0.98 ± 0.61 1.27 ± 0.77
HDL 1.52 ± 0.36 1.51 ± 0.38
LDL* 2.74 ± 0.78 3.38 ± 0.90
Cholesterol* 4.80 ± 0.83 5.51 ± 0.99
*significant difference between pre and post-menopausal women (p < 0.05) Mean
± Standard Deviation (SD), HOMA-IR, Homeostatic Model of Assessment-Insulin
Resistance; HOMA-β, Homeostatic Model of Assessment-Beta Cell; HDL, High Density
Lipoprotein; LDL, Low Density Lipoprotein.
no significant correlations after controlling for all confounding
variables (Table 6). The correlation between YFAS symptoms
and HOMA-β was strongest for men and TG exhibited the only
significant correlation strongest for post-menopausal women.
Comparison of Food Addicts and Non-food
Addicts
No significant difference was observed between BMI matched FA
and NFA individuals from the general population for markers of
IR or lipid profiles. These groups consisted of obese, overweight
and normal weight individuals. When separated by sex, there
was still no statistically significant differences observed in men
or women (Table 7). FA men had significantly lower HDL levels
than FA women.
DISCUSSION
In Canada, between 1985 and 2011 the rate of obesity leapt
from 6.1 to 18.3% (33). Not surprisingly, the rapid rise in
obesity over the same time span is paralleled by a substantial
rise in diabetes both in Canada and globally (34, 35). There is
evidence supporting the role of processed and fast foods as key
contributors to the obesity epidemic and it is worth noting that
these same types of foods may override the body’s normal satiety
signals leading to overconsumption (36–40). Similar findings
have been produced in animal studies. Rats who were subjected
to stress consumed up to 160% more food when given just a taste
of highly palatable food as opposed to rats given just standard
chow (41). While hunger related hormones such as ghrelin and
leptin were not included in our analysis, the role they potentially
play in food addiction and the metabolic consequences thereof,
should not be understated. Leptin, one of the bodies main
satiety promoting hormones, was found to decrease feeding-
evoked dopamine release in rats while another study found
that ghrelin signaling, which induces hunger, is key to driving
the consumption of “rewarding” foods. This study also showed
that dopamine release was absent in ghrelin receptor knock-out
Frontiers in Endocrinology | www.frontiersin.org 4 November 2018 | Volume 9 | Article 661
Nelder et al. Food Addiction and Metabolic Characteristics
Table 3 | Correlations between YFAS symptom counts and metabolic characteristics in men.
YFAS Symptom Counts Men (n = 275)
r1(P) r2(P) r3(P) r4(P) r5(P)
Insulin (pmol/L) 0.248 (0.001)* 0.248 (0.001)* 0.231 (0.002)* 0.140 (0.064)* 0.135 (0.080)
HOMA-IR 0.262 (0.001)* 0.271 (0.001)* 0.255 (0.002)* 0.167 (0.048)* 0.164 (0.053)
HOMA-β 0.316 (0.000)* 0.302 (0.000)* 0.283 (0.001)* 0.201 (0.016)* 0.196 (0.021)*
Glucose (mmol/L) −0.075 (0.217) −0.040 (0.511) −0.048 (0.440) −0.075 (0.224) −0.070 (0.260)
TG (mmol/L) 0.205 (0.001)* 0.222 (0.000)* 0.203 (0.001)* 0.137 (0.026)* 0.140 (0.025)*
HDL (mmol/L) −0.232 (0.000)* −0.222 (0.000)* −0.201 (0.001)* −0.137 (0.025)* −0.133 (0.033)*
LDL (mmol/L) −0.031 (0.614) 0.004 (0.947) −0.005 (0.935) −0.059 (0.342) −0.055 (0.378)
Cholesterol (mmol/L) −0.006 (0.917) 0.040 (0.511) 0.020 (0.640) −0.025 (0.683) −0.019 (0.756)
*p-value < 0.05, r1-pearson correlation, r2-controlled for age, r3-controlled for age, physical activity, r4-controlled for age, physical activity, total % body fat, r5-controlled for age,
physical activity, total % body fat, calories.
Table 4 | Correlations between YFAS symptom counts and metabolic characteristics in women.
YFAS Symptom Counts Women (n = 435)
r1(P) r2(P) r3(P) r4(P) r5(P)
Insulin (pmol/L) 0.084 (0.221) 0.086(0.209) 0.069 (0.319) 0.011 (0.880) 0.021 (0.766)
HOMA-IR 0.066 (0.355) 0.064 (0.370) 0.054 (0.458) 0.049 (0.496) 0.036 (0.624)
HOMA-β 0.071 (0.319) 0.064 (0.372) 0.052 (0.468) 0.005 (0.947) 0.021 (0.777)
Glucose (mmol/L) −0.039 (0.423) −0.024 (0.622) −0.042 (0.388) −0.080 (0.102) −0.085 (0.081)
TG (mmol/L) 0.122 (0.011)* 0.131 (0.007)* 0.110 (0.023)* 0.059 (0.224) 0.065 (0.152)
HDL (mmol/L) −0.112 (0.020)* −0.110 (0.022)* −0.082 (0.092) −0.010 (0.841) −0.010 (0.835)
LDL (mmol/L) −0.015 (0.750) 0.004 (0.940) −0.001 (0.980) −0.028 (0.567) −0.030 (0.537)
Cholesterol (mmol/L) 0.011 (0.824) 0.035 (0.465) −0.032 (0.514) 0.018 (0.714) 0.017 (0.732)
*p-value < 0.05, r1-pearson correlation, r2-controlled for age, r3-controlled for age, physical activity, r4- controlled for age, physical activity and total % body fat, r5- controlled for age,
physical activity and total % body fat, calories.
mice (42, 43). This is important to consider from a metabolic
health standpoint as well because other animal studies have
also shown that leptin may reduce adiposity independent of
caloric intake which suggest leptin levels could also affect other
metabolic characteristics, even if indirectly (44). Furthermore,
an investigation of the effects of a ghrelin infusion found that
glucose utilization in rats increased in both white and brown fat
cells (45). It is possible that the levels of these hunger related
hormones in our own cohort may have had some effect on the
metabolic characteristics that were measured. The very same
foods which possess addictive qualities, can lead to a cascade of
metabolic disturbances if frequently consumed (16, 17, 46, 47)
which contribute to the development of diabetes and CVD (48–
50). This marks the need for more exploration of the relationship
between an addictive tendency toward food and health. No
study, to our knowledge, has explored the association between an
addictive tendency toward food and metabolic characteristics in
the general population. A better understanding of how symptoms
of food addiction are associated with IR and lipid profiles would
help us better comprehend the impact of specific eating behaviors
on health.
The main finding produced from our study was that in adult
males, despite not meeting the criteria for a “food addiction”
diagnosis, YFAS symptom counts were still significantly,
associated with HOMA-β and TG levels as well as inversely
associated with HDL levels. Both HOMA-IR and HOMA-β have
been implicated in diabetes risk in the past (51). HOMA-β, a
measure of insulin secretion, has also been found to initially
parallel rising TG levels in newly diagnosed type 2 diabetics
only to decrease as TG levels continued to rise higher (52).
Interestingly, HOMA-β levels tend to be lower in individuals with
a family history of diabetes due to lower levels of insulin secretion
as a result of impaired β-cell function (53). The aforementioned
studies demonstrate the complexity of the relationship between
insulin secretion and metabolic health. In the current study,
there was a significant positive correlation between HOMA-
β and YFAS symptom counts which may suggest that food
addicted behaviors result in higher insulin secretion as a
compensatory mechanism. This could potentially be problematic
as consistently high insulin levels can often precede diabetes
which can eventually damage the β-cell to the point where the
cell can no longer produce sufficient levels of insulin to combat
hyperglycemia. This is evidenced by the enlargement of β-cells
observed in obese individuals and those in the pre-diabetic phase
(54–56). HOMA-βmeasurements, therefore, must be interpreted
cautiously as high insulin secretion can suggest an individual is at
risk of developing diabetes and low insulin secretion may suggest
that the damage has already been done to the β-cell. A study by
the CanadianHeart Health Surveys ResearchGroup found that in
a sample of over 29 000 Canadians, high TG and low HDL levels
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Table 5 | Correlations between YFAS symptom counts and metabolic characteristics in post-menopausal women.
YFAS Symptom Counts Females (n = 158)
r1(P) r2(P) r3(P) r4(P) r5(P)
Insulin (pmol/L) 0.021 (0.841) 0.013 (0.913) 0.020 (0.853) −0.027 (0.803) 0.009 (0.936)
HOMA-IR 0.015 (0.889) 0.014 (0.899) 0.018 (870) −0.024 (833) 0.015 (0.897)
HOMA-β 0.032 (0.763) 0.016 (0.880) 0.033 (0.763) −0.009 (0.934) 0.032 (0.778)
Glucose (mmol/L) −0.047 (0.557) −0.035 (0.664) −0.058 (0.477) −0.087 (0.920) −0.089 (0.223)
TG (mmol/L) 0.227 (0.004)* 0.226 (0.004)* 0.216 (0.007)* 0.191 (0.019)* 0.198 (0.016)*
HDL (mmol/L) −0.029 (0.715) −0.010 (0.902) 0.008 (0.922) 0.064 (0.438) −0.032 (0.701)
LDL (mmol/L) −0.098 (0.218) −0.086 (0.285) −0.089 (0.274) −0.084 (0.303) −0.098 (0.235)
Cholesterol (mmol/L) 0.024 (0.765) 0.045 (0.577) 0.040 (0.626) 0.059 (0.475) 0.041 (0.619)
*p-value < 0.05, r1-pearson correlation, r2-controlled for age, r3-controlled for age, physical activity, r4-controlled for age, physical activity, total % body fat, r5-controlled for age,
physical activity, total % body fat, calories.
Table 6 | Correlations between YFAS symptom counts and metabolic characteristics in pre-menopausal women.
YFAS Symptom Counts Females (n = 277)
r1(P) r2(P) r3(P) r4(P) r5(P)
Insulin (pmol/L0 0.141 (0.120) 0.142 (0.119) 0.113 (0.227) 0.052 (0.571) 0.053 (0.572)
HOMA-IR 0.087 (0.366) 0.087 (0.369) 0.071 (0.468) 0.073 (0.455) 0.059 (0.546)
HOMA-β 0.097 (0.314) 0.103 (0.285) 0.076 (0.432) 0.031 (0.753) 0.037 (0.709)
Glucose (mmol/L) −0.012 (0.843) −0.017 (0.784) −0.032 (0.602) −0.073 (0.234) −0.079 (0.201)
TG (mmol/L) 0.078 (0.200) 0.077 (0.204) 0.049 (0.418) −0.016 (0.790) −0.012 (0.842)
HDL (mmol/L) −0.162 (0.007)* −0.163 (0.007)* −0.128 (0.035)* −0.054 (0.377) −0.047 (0.441)
LDL (mmol/L) 0.066 (0.277) 0.064 (0.288) 0.066 (0.282) 0.017 (0.778) 0.017 (0.788)
Cholesterol (mmol/L) 0.038 (0.528) 0.036 (0.556) 0.036 (0.559) −0.001 (0.985) 0.001 (0.990)
*p-value <0.05, r1-pearson correlation, r2-controlled for age, r3-controlled for age, physical activity, r4-controlled for age, physical activity, total % body fatr5-controlled for age, physical
activity, total % body fat, calories.
were common among diabetics and those with hypertension (57).
Elevated TG levels have also been associated with atherosclerotic
CVD and all cause mortality in a study comprised of over
15 000 patients (58, 59). It stands that behaviors that may
influence TG and HDL levels may also increase the risk of CVD.
There is currently limited research on the relationship between
food addiction, its symptoms and their relationship with these
metabolic characteristics, however, one study did find that food
addiction was significantly more prevalent in newly diagnosed
type 2 diabetics when compared to a control group. This same
study also compared the metabolic characteristics of FA and
NFA diabetics and found that those who were food addicted
had a substantially higher HOMA-IR value (60). However, our
own results indicated that there was no significant difference in
HOMA-IR or other metabolic characteristics between FA and
NFA individuals when matched for BMI. Food addiction has
also been found to account for a large portion of BMI variance
among T2D patients (61). This may suggest that an addictive
tendency toward food is not only a risk factor for T2D but
could in fact exasperate the condition since patients will have
greater difficulties adhering to dietary recommendations that
may improve their health and help manage their condition. As
previously noted, some of the hormones associated with addictive
behaviors also share associations with a number of health risks
whichmay further compound the effects of an addictive tendency
toward food.
In females, Pearson correlation analysis revealed no significant
correlations between YFAS symptoms and any of the metabolic
markers measured. However, after women were separated
according to menopausal status to further elucidate the potential
effects of sex hormones on these outcomes, post-menopausal
women exhibited a significant correlation between YFAS
symptoms and TG after correcting for age, physical activity,
total body fat percent and calories. While there are currently
no past studies investigating the association between YFAS
symptoms and metabolic abnormalities in women, other studies
on disordered eating patterns such as binge eating have been
found to have signification associations with T2D (62). The role
of addictive food tendencies in T2D have also been found to
be harmful. Varying levels of food addiction based on YFAS
symptom counts were associated with significant increased in
BMI among T2D patients in a sample that was 67.4% women,
however, there was no adjustment for menopausal status (63).
The limited associations seen in our female population may be
due to the protective effects of lower body fat common among
women which may help keep blood glucose and lipid profiles
within a normal range in spite of problematic eating behaviors
(64–66). However, this effect could be somewhat diminished in
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Table 7 | Metabolic Marker Measures in BMI Matched Food and Non-Food Addicted Individuals.
Total Population Men Women
FA NFA FA NFA FA NFA
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
n = 38 n = 38 n = 9 n = 9 n = 29 n = 29
Insulin (pmol/L) 122.1 ± 132.2 87.9 ± 41.8 231.3 ± 84.6 96.4 ± 33.9 81.9 ± 35.4 84.4 ± 45.0
HOMA-IR 0.75 ± 1.40 0.45 ± 0.20 1.99 ± 2.85 0.50 ± 0.15 0.40 ± 0.22 0.43 ± 0.22
HOMA-β 2.14 ± 0.24 2.13 ± 0.17 2.20 ± 0.40 2.15 ± 0.18 2.12 ± 0.18 2.12 ± 0.18
Glucose (mmol/L) 5.44 ± 1.20 5.14 ± 0.41 6.37 ± 2.09 5.29 ± 0.36 5.14 ± 0.50 5.09 ± 0.42
TG (mmol/L) 1.32 ± 0.70 1.29 ± 0.75 1.50 ± 0.69 1.50 ± 0.95 1.26 ± 0.71 1.23 ± 0.68
HDL (mmol/L)* 1.36 ± 0.35 1.37 ± 0.31 1.06 ± 0.17 1.12 ± 0.26 1.46 ± 0.34 1.44 ± 0.29
LDL (mmol/L) 3.18 ± 1.07 3.00 ± 0.77 3.06 ± 1.48 3.09 ± 0.45 3.22 ± 0.93 2.97 ± 0.85
Cholesterol (mmol/L) 5.19 ± 1.23 5.00 ± 0.91 4.80 ± 1.52 4.88 ± 0.74 5.32 ± 1.14 5.04 ± 0.97
*significant difference between FA men and women at p < 0.05 Mean ± standard deviation(SD) FA, Food Addict; NFA, Non-Food Addict; HOMA-IR, Homeostatic Model of
Assessment-Insulin Resistance; HOMA-β, Homeostatic Model of Assessment-Beta Cell; TG, Triglyceride; HDL, High Density Lipoprotein; LDL, Low density Lipoprotein.
post-menopausal women as decreasing estrogen levels have been
shown influence central fat accumulation and TG levels (67, 68)
The greatest strength of our study is the large number of
individuals successfully recruited from the general population in
conjunction with good screening efforts to control for potential
confounders such as health disorders that could influence
an individual’s dietary habits or result in them presenting
with addictive behaviors beyond that which is seen a general
population. We have also benefitted from the ability to collect
blood samples from every participant for reliable measurement of
hormones and lipid profiles. Our extensive list of questionnaires
to collect details on physical activity and dietary history add
strength to the validity of our results as they allowed us to
effectively control for these confounders. The use of DXA
scanning to measure total body fat % ensured this particular
confounding variable was measured using one of the most
accurate methods available (69). One possible limitation present
in our study could be that caloric intake and physical activity
levels were self-reported, both of which were controlled for in
this study. Self-reporting is of course prone to the self-reporting
bias which researchers must be cognizant of. The number of food
addicts used in the comparative analysis was also small as food
addiction is only present in 5.4% of this particular population
(70). It should also be noted that the exclusion of previously
diagnosed food addicted individuals contributed to the modest
correlation coefficients produced from the partial correlation
analysis. However, exclusion of these outliers allowed us to
better capture the true contribution of addictive eating tendencies
to metabolic disturbance in a general population. Replications
of this study would greatly benefit from a larger number of
diagnosed food addicts. It is also possible that with a larger
overall sample size, the correlation between YFAS symptoms and
HOMA-IR in men may reach the required cut-off for statistical
significance as it was narrowly missed in this analysis (Table 3).
Future studies could also benefit frommeasuring a larger number
of metabolic markers or health outcomes and their association
with an addictive tendency toward food. Finally, an intervention
study measuring metabolic characteristics in food addicts before
and after treatment to address addictive eating behaviors would
better highlight the impact these behaviors have on health and
whether meaningful improvements in IR and lipid profiles can
be achieved through this.
In conclusion, we have demonstrated that an addictive
tendency toward food is associated with several metabolic
characteristics that may contribute to insulin resistance and
CVD in men of the general Newfoundland population and
to a lesser extent, post-menopausal women. Our findings help
elucidate the role of addictive food tendencies in metabolic
disturbance in a general population and how this may impact
men and women differently. Addressing these behaviors through
therapy or lifestyle change may be beneficial to an individual’s
overall health. Furthermore, efforts to control addictive eating
behaviors could potentially become a factor in preventative
efforts concerning diabetes and CVD in the future.
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